Interventional Cardiology Research

Investigator-Initiated Research

Principal Investigator	Study Title	Funding Agencies
Gregory Marcus, MD	Transseptal vs. Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli	PCORI

Principal Investigator	Study Title	Funding Agencies
Sammy Elmariah, MD	Electronic Physician Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: The DETECT AS Trial Condition(s): Aortic Stenosis	Edwards Lifesciences
Sammy Elmariah, MD	The HALT Biomarker Study Condition(s): Aortic Stenosis,Hypo-attenuated Leaflet Thickening,Bioprosthetic Valve Degeneration	Medtronic Catholic Medical Center Minneapolis Heart Institute
Sammy Elmariah, MD	Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) Condition(s): Aortic Valve Stenosis	Cardiovascular Research Foundation, New York
Sammy Elmariah, MD	Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial Condition(s): Degenerative Mitral Valve Disease,Mitral Regurgitation,Mitral Insufficiency,Functional Mitral Regurgitation	Edwards Lifesciences
Sammy Elmariah, MD	TRISCEND II Pivotal Trial Condition(s): Tricuspid Valve Regurgitation,Tricuspid Valve Insufficiency,Tricuspid Valve Disease,Heart Valve Diseases,Cardiovascular Diseases,Heart Failure	Edwards Lifesciences
Sammy Elmariah, MD	Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial Condition(s): Tricuspid Regurgitation,Tricuspid Valve Insufficiency,Tricuspid Valve Disease	Edwards Lifesciences
Sammy Elmariah, MD	2019-06 TRISCEND Study Condition(s): Tricuspid Valve Regurgitation,Heart Valve Diseases,Cardiovascular Diseases	Edwards Lifesciences